Author

K. L. Jensen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 3 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 1 Approach:statistical model· 1

Frequent Co-Authors

C. M. Goddard· 2 shared K. L. Madsen· 2 shared A. B. I. Soltan· 1 shared A. Jakobsen· 1 shared A. Patwardhan· 1 shared A. Schafer· 1 shared A. T. Soerensen· 1 shared A.-M. Heegaard· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

C. M. Goddard

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Venom-inspired somatostatin receptor 4 (SSTR4) agonists as new drug leads for peripheral pain conditions

W. E. Bjorn-Yoshimoto, I. B. L. Ramiro, T. L. Koch, E. Engholm, H. Y. Yeung, K. K. Sorensen, C. M. Goddard, K. L. Jensen, N. A. A. Smith, L. F. Martin, B. J. Smith, K. L. Madsen, K. J. Jensen, A. Patwardhan, H. Safavi-Hemami

This study identifies venom-derived SSTR4 agonists as potential non-opioid therapeutics for peripheral pain conditions.

bioRxiv · Apr 29, 2024 · PreprintPharmacology & Toxicology

mPD5, a peripherally restricted PICK1 inhibitor for treating chronic pain

K. L. Jensen, N. R. Christensen, C. M. Goddard, S. E. Jager, I. B. Kanneworff, A. Jakobsen, G. Noes-Holt, L. Jimenez-Fernandez, E. G. Peck, L. Sivertsen, R. C. Baro, G. A. Houser, F. P. Mayer, M. D. del Castillo, M. L. Topp, , K. L. Madsen

This paper develops mPD5, a peripherally restricted PICK1 inhibitor that reduces chronic pain and associated symptoms in mice without significant side effects.

bioRxiv · Mar 3, 2023 · PreprintPharmacology & Toxicology

Common Mechanism of SARS-CoV and SARS-CoV-2 Pathogenesis across Species

A. Schafer, L. E. Gralinski, S. R. Leist, E. S. Winkler, B. K. Hampton, M. A. Mooney, K. L. Jensen, R. L. Graham, S. Agnihothram, S. Jeng, S. Chamberlin, T. A. Bell, D. T. Scobey, L. A. VanBlargan, L. B. Thackray, , R. S. Baric

The paper identifies host susceptibility loci for SARS-CoV and SARS-CoV-2 using GWAS and Collaborative Cross datasets, validating CCR9 as a key regulator of severe disease outcomes across species.

bioRxiv · May 14, 2021 · PreprintMicrobiology